Publications in collaboration with researchers from University of Tampere (17)

2023

  1. Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

    Nature

2022

  1. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)

    Nature Communications

  2. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1)

    Nature Communications

  3. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

    Nature Communications

  4. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer (Nature Communications, (2020), 11, 1, (733), 10.1038/s41467-019-13824-9)

    Nature Communications

  5. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w)

    Nature Communications

  6. Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

    Nature Communications

  7. Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9)

    Nature Communications

  8. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0)

    Nature Communications

  9. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig (Nature Communications, (2020), 11, 1, (731), 10.1038/s41467-020-14352-7)

    Nature Communications

2021

  1. Subclone eradication analysis identifies targets for enhanced cancer therapy and reveals L1 retrotransposition as a dynamic source of cancer heterogeneity

    Cancer Research, Vol. 81, Núm. 19, pp. 4901-4909

2020

  1. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)

    Nature Communications

  2. Author Correction: The evolutionary history of lethal metastatic prostate cancer (Nature, (2015), 520, 7547, (353-357), 10.1038/nature14347)

    Nature

  3. Pan-cancer analysis of whole genomes

    Nature, Vol. 578, Núm. 7793, pp. 82-93

  4. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

    Nature Communications, Vol. 11, Núm. 1

  5. Sex differences in oncogenic mutational processes

    Nature Communications, Vol. 11, Núm. 1

2014

  1. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Science, Vol. 345, Núm. 6196